Symposium on rectal cancer: 3. The case for adjuvant radiotherapy for rectal cancer

Canadian Journal of Surgery

Volumn 40, Issue 5, 1997, Pages 358-362

  Cummings, Bernard J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; CANCER RECURRENCE; CHEMOTHERAPY; CONFERENCE PAPER; HUMAN; MORBIDITY; PREOPERATIVE RADIOTHERAPY; RECTUM CANCER; RECURRENCE RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; SYMPOSIUM;

HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0030829093     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Hcald RJ, Ryall RD. The mesorectum in rectal cancer surgery -the clue to pelvic recurrence? BrJSmy 1982;69:613-6.
2. EnkerWE, Pilipshen SJ, Heihvcil ML, Stearns MW Jr, Janov AJ, Hertz RE, et al. En bloc pelvic lymphadenectomy and sphincter preservation in the surgical management of rectal cancer. Ann Sing 1986;203:426-33.
3. MacFarlane JK, Ryall RDH, Heald RJ. Mcsorectal excision for rectal cancer. Lancet 1993;341:457-60.
4. McCall JL, Cox MR, Wattchow DA. Analysis of local recurrence rates after surgery alone for rectal cancer. IntJ Colorectal Dis 1995;10:126-32.
5. Cummings BJ. Adjuvant treatment for rectal cancer. Semin Colon Rectal Sing 1996;7:47-54.
6. Dahl O, Horn A, Morild I, Halvorsen JF, Ödland G, Reinertsen S, et al. Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicentcr trial in western Norway [review]. Cancer 1990;66:2286-94.
7. Gerard A, Buyse M, Nordlinger B, Loygue J, Pêne F, Kempf P, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Sing 1988;208:606-14.
8. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Rectal Cancer Study Group. Cancer 1990;66:49-55.
9. Increased 5-years survival after preoperative irradiation in rectal cancer. Swedish Rectal Cancer Trial [abstract]. IntJ Colorectal Dis 1996;11:128.
10. Prolongation of the disease-free interval in surgically treated rectal cancer. Gastrointestinal Tumor Study Group. N Engl J Me A 1985;312: 1465-72.
11. Douglass HO Jr, Moertel CG, Mayer RJ, Thomas PR, Lindblad AS, Mittleman A, et al. Survival after postopr erative combination treatment of rectal cancer [letter]. N Engl J Med 1986;315:1294-5.
12. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickcrham DL, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer lust 1988;80:21-9.
13. Balslev I, Pederson M, Teglbjaerg PS, Hanberg-Soerensen F, Bone J, Jacobsen NO, et al. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Gi;/;-1986;5S:22-8.
14. Bentzen SM, Balslev I, Pedersen M, Teglbjaerg PS, Hanberg-Soerensen F, Bone J, et al. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multi-variate regression analysis. BrJ Cancer 1992; 65:102-7.
15. Treurniet-Donker AD, van Putten WL, Wereldsma JC, Bruggink ED, Hoogenraad WJ, Roukema JA, et al. Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The Netherlands [see comments]. Cancer 1991;67:2042-8. Comments in: Cancer 1992;69:30167;Gjnrl992;69:3017-9.
16. Buyse M, Zelenuich-Jacquotte A, Chalmers T. Adjuvant therapy of colorectal cancer: why we still don't lixiow.JAMA 1988;259:3571-8.
17. Gray R, James R, Mossman J, Stenning S. AXIS -a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee [editorial]. Er J Cancer 1991; 63; 841-5
18. Phillips TL. Biochemical modifiers. In: Mauch PM, Loeffler JS, editors. Radiation oncology, technology and biology. Philadelphia: WB Saunders; 1994. p. 113-51.
19. Boulis-Wassif S, Gérard A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. CHrl984;53:1811-8.
20. Tveit KM, Guldvog I, Hagen S, Trondsen E, Harbitz T, Nygaard K, et al. Improved treatment results in rectal cancer by postoperative radiotherapy and 5-fluorouracil [abstract]. Enr J Cancer 1995;31ASuppl 5:S146.
21. Mansour EG, Letkopoulou M, Johnson R, Douglass H. A comparison of postoperative adjuvant chemotherapy, radiotherapy or combined ther-apy in potentially curable rectal carcinoma [abstract]. Proc Am Soc Clin Oncol 1991;10:154.
22. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma [see comments]. NEtijjlJMed 1991; 324:709-15. Comments in: NEnglJ Med 1991;324:764-6; NEtiglJMed 1991;325:519-20.
23. Kollmorgen CF, Meagher AP, Wolff BG, Pcmberton JH, Alartenson JA, Illstrup DM. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994; 220:676-82.
24. Pahlman L, Glimelius B. The value of adjuvant radio(chemo)therapy for rectal cancer [review]. EtirJ Cancer 1995;31A:1347-50.
25. Rice DC, Nelson H. Tumor markers in colorectal cancer: predictors of risk. Semin Colon Rectal Siny 1996;7: 16-30.
26. Moriya Y, Hojo K, Sawada T, Koyama Y. Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 1989;32:307-15.
27. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer [see comments]. Lancet 1994;344:707-11. Comments in: Lancet 1994;344:1153-4; Lancet 1994; 344:1431.
28. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival [see comments]. BMJ 1991;302:1501-5. Comments in: BMJ 1991;303:247-8; BMJ 1991; 303:419-20.
29. Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma -experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tiimori 1995;81(3 Suppl):60-4.